Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis Mar. 2010;55(3):590–8. https://doi.org/10.1053/j.ajkd.2009.06.044.
Poulter NR, Prabhakaran D, Caulfield M, Hypertension. Lancet. Aug 22 2015;386(9995):801 – 12. https://doi.org/10.1016/s0140-6736(14)61468-9
Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. Oct 23 2018;138(17):e426-e483. https://doi.org/10.1161/cir.0000000000000597
Weycker D, Nichols GA, O’Keeffe-Rosetti M, Edelsberg J, Khan ZM, Kaura S, Oster G. Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens Jun. 2007;20(6):599–607. https://doi.org/10.1016/j.amjhyper.2006.10.013.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol Apr. 2020;16(4):223–37. https://doi.org/10.1038/s41581-019-0244-2.
Belletti DA, Zacker C, Wogen J. Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States. Cardiovasc Diabetol Feb 1. 2010;9:7. https://doi.org/10.1186/1475-2840-9-7.
Wei J, Mi Y, Li Y, Xin B, Wang Y. Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey. BMC Public Health Mar. 2021;1(1):423. https://doi.org/10.1186/s12889-021-10417-4.
Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens Apr. 2015;29(4):247–53. https://doi.org/10.1038/jhh.2014.82.
Khdour MR, Hallak HO, Shaeen M, Jarab AS, Al-Shahed QN. Prevalence, awareness, treatment and control of hypertension in the Palestinian population. J Hum Hypertens Oct. 2013;27(10):623–8. https://doi.org/10.1038/jhh.2013.26.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH, ASPC/NMA/PCNA Guideline for the Prevention. /, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. Jun 2018;71(6):e13-e115. https://doi.org/10.1161/hyp.0000000000000065
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J Sep. 2018;1(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339.
Pescatello LS, Buchner DM, Jakicic JM, Powell KE, Kraus WE, Bloodgood B, Campbell WW, Dietz S, Dipietro L, George SM, et al. Physical activity to prevent and treat hypertension: a systematic review. Med Sci Sports Exerc. Jun 2019;51(6):1314–23. https://doi.org/10.1249/mss.0000000000001943.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertens Nov. 2003;42(5):878–84. https://doi.org/10.1161/01.Hyp.0000094221.86888.Ae.
Graudal N, Hubeck-Graudal T, Jürgens G, Taylor RS. Dose-response relation between dietary sodium and blood pressure: a meta-regression analysis of 133 randomized controlled trials. Am J Clin Nutr May. 2019;1(5):1273–8. https://doi.org/10.1093/ajcn/nqy384.
Kotseva K, Jennings CS, Turner EL, Mead A, Connolly S, Jones J, Bowker TJ, Wood DA. ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK. Heart Jun. 2012;98(11):865–71. https://doi.org/10.1136/heartjnl-2011-301603.
Tang L, Patao C, Chuang J, Wong ND. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007–2010). Am J Cardiol Oct. 2013;15(8):1126–32. https://doi.org/10.1016/j.amjcard.2013.05.064.
De Smedt D, De Sutter J, De Pauw M, Vandekerckhove H, Trouerbach J, De Backer G, Willems AM, Pardaens S, Vervaet P, Deweerdt N, et al. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys. Acta Cardiol Feb. 2019;74(1):21–7. https://doi.org/10.1080/00015385.2018.1438092.
Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol May. 2019;26(8):824–35. https://doi.org/10.1177/2047487318825350.
Kilic S, Sümerkan M, Emren V, Bekar L, Cersit S, Tunc E, Gök G, Altuntas E, Canpolat U, Sinan UY, et al. Secondary prevention of coronary heart disease in elderly population of Turkey: a subgroup analysis of ELDERTURK study. Cardiol J. 2019;26(1):13–9. https://doi.org/10.5603/CJ.a2017.0113.
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil Apr. 2009;16(2):121–37. https://doi.org/10.1097/HJR.0b013e3283294b1d.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens Jun. 2020;38(6):982–1004. https://doi.org/10.1097/hjh.0000000000002453.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama May. 2001;16(19):2486–97. https://doi.org/10.1001/jama.285.19.2486.
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care Jan. 2023;1(Suppl 1):S19–40. https://doi.org/10.2337/dc23-S002.
Andrassy KM. Comments on ‘KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease’. Kidney Int Sep. 2013;84(3):622–3. https://doi.org/10.1038/ki.2013.243.
Smith SC Jr., Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation Nov. 2011;29(22):2458–73. https://doi.org/10.1161/CIR.0b013e318235eb4d.
Tang Y, Yan J, Tang L, Liu X. Risk factor control among heart failure patients in the United States: results from the NHANES 1999–2018. Int J Cardiol Cardiovasc Risk Prev Jun. 2022;13:200128. https://doi.org/10.1016/j.ijcrp.2022.200128.
Zhang Z, Du C, Zhong X, Wang R, Tang L, Liu X. The secondary prevention of coronary heart disease in US adults 75 years and older in daily practice: results from the National Health and Nutrition Examination Survey 1999–2018 survey. Heliyon Apr. 2024;15(7):e28239. https://doi.org/10.1016/j.heliyon.2024.e28239.
Vyssoulis GP, Karpanou EA, Liakos CI, Kyvelou SM, Tzamou VE, Michaelides AP, Triantafyllou AI, Spanos PG, Stefanadis CI. Cardiovascular risk factor(s) prevalence in Greek hypertensives. Effect of gender and age. J Hum Hypertens Jul. 2012;26(7):443–51. https://doi.org/10.1038/jhh.2011.55.
Goldberg RB. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes. Am J Manag Care Aug. 2000;6(13 Suppl):S682–91. discussion S692-6.
Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation May. 2003;6(17):2185–9. https://doi.org/10.1161/01.Cir.0000066320.27195.B4.
Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health Oct. 2018;6(10):e1077–86. https://doi.org/10.1016/s2214-109x(18)30357-7.
Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, Colditz GA. Body weight, weight change, and risk for hypertension in women. Ann Intern Med Jan. 1998;15(2):81–8. https://doi.org/10.7326/0003-4819-128-2-199801150-00001.
Tocci G, Ferrucci A, Pontremoli R, Ferri C, Rosei EA, Morganti A, Trimarco B, Mancia G, Borghi C, Volpe M. Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys. J Hum Hypertens Nov. 2015;29(11):696–701. https://doi.org/10.1038/jhh.2015.4.
Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med Apr. 2002;2(7):493–503. https://doi.org/10.7326/0003-4819-136-7-200204020-00006.
Lesniak KT, Dubbert PM. Exercise and hypertension. Curr Opin Cardiol Nov. 2001;16(6):356–9. https://doi.org/10.1097/00001573-200111000-00007.
Börjesson M, Onerup A, Lundqvist S, Dahlöf B. Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs. Br J Sports Med. Mar 2016;50(6):356–61. https://doi.org/10.1136/bjsports-2015-095786.
Yang MH, Kang SY, Lee JA, Kim YS, Sung EJ, Lee KY, Kim JS, Oh HJ, Kang HC, Lee SY. The Effect of Lifestyle changes on blood pressure control among hypertensive patients. Korean J Fam Med Jul. 2017;38(4):173–80. https://doi.org/10.4082/kjfm.2017.38.4.173.
Stenehjem JS, Hjerkind KV, Nilsen TIL. Adiposity, physical activity, and risk of hypertension: prospective data from the population-based HUNT Study, Norway. J Hum Hypertens Apr. 2018;32(4):278–86. https://doi.org/10.1038/s41371-018-0042-5.
Alefan Q, Huwari D, Alshogran OY, Jarrah MI. Factors affecting hypertensive patients’ compliance with healthy lifestyle. Patient Prefer Adherence. 2019;13:577–85. https://doi.org/10.2147/ppa.S198446.
Conklin DJ, Schick S, Blaha MJ, Carll A, DeFilippis A, Ganz P, Hall ME, Hamburg N, O’Toole T, Reynolds L, et al. Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation. Am J Physiol Heart Circ Physiol. Apr 2019;1(4):H801–27. https://doi.org/10.1152/ajpheart.00591.2018.
Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L. Cigarette smoking and hypertension. Curr Pharm Des. 2010;16(23):2518–25. https://doi.org/10.2174/138161210792062920.
Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities Study. Hypertens May. 2001;37(5):1242–50. https://doi.org/10.1161/01.hyp.37.5.1242.
Fuchs FD, Fuchs SC. The Effect of Alcohol on blood pressure and hypertension. Curr Hypertens Rep Nov. 2021;11(10):42. https://doi.org/10.1007/s11906-021-01160-7.
Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, Engell RE, Lim SS, Danaei G, Mozaffarian D. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open Dec. 2013;23(12):e003733. https://doi.org/10.1136/bmjopen-2013-003733.
Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens Mar. 2005;23(3):475–81. https://doi.org/10.1097/01.hjh.0000160199.51158.cf.
Beauchamp A, Peeters A, Wolfe R, Turrell G, Harriss LR, Giles GG, English DR, McNeil J, Magliano D, Harrap S, et al. Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors. J Epidemiol Community Health Jun. 2010;64(6):542–8. https://doi.org/10.1136/jech.2009.094516.
Bruthans J, Mayer O Jr., De Bacquer D, De Smedt D, Reiner Z, Kotseva K, Cífková R. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol May. 2016;23(8):881–90. https://doi.org/10.1177/2047487315601078.
Landon BE, Hatfield LA, Bakx P, Banerjee A, Chen YC, Fu C, Gordon M, Heine R, Huang N, Ko DT, et al. Differences in Treatment Patterns and outcomes of Acute myocardial infarction for low- and high-income patients in 6 countries. Jama Apr. 2023;4(13):1088–97. https://doi.org/10.1001/jama.2023.1699.
Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20(2):157–72. https://doi.org/10.1093/oxfordjournals.epirev.a017978.
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their Cardiovascular complications. Circ Res May. 2016;27(11):1723–35. https://doi.org/10.1161/circresaha.115.306825.
Carmena R, Ascaso JF, Redon J. Chronic kidney disease as a cardiovascular risk factor. J Hypertens Nov. 2020;38(11):2110–21. https://doi.org/10.1097/hjh.0000000000002506.
